736 related articles for article (PubMed ID: 22669598)
41. Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis.
Berard RA; Laxer RM
Expert Opin Biol Ther; 2013 Nov; 13(11):1623-30. PubMed ID: 24070010
[TBL] [Abstract][Full Text] [Related]
42. Therapeutic use of etanercept in polyarticular course juvenile idiopathic arthritis over a two year period.
Kietz DA; Pepmueller PH; Moore TL
Ann Rheum Dis; 2002 Feb; 61(2):171-3. PubMed ID: 11796406
[TBL] [Abstract][Full Text] [Related]
43. Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis.
Tynjälä P; Lindahl P; Honkanen V; Lahdenne P; Kotaniemi K
Ann Rheum Dis; 2007 Apr; 66(4):548-50. PubMed ID: 17068061
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.
Quartier P; Taupin P; Bourdeaut F; Lemelle I; Pillet P; Bost M; Sibilia J; Koné-Paut I; Gandon-Laloum S; LeBideau M; Bader-Meunier B; Mouy R; Debré M; Landais P; Prieur AM
Arthritis Rheum; 2003 Apr; 48(4):1093-101. PubMed ID: 12687553
[TBL] [Abstract][Full Text] [Related]
45. Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy.
Aikawa NE; França IL; Ribeiro AC; Sallum AM; Bonfa E; Silva CA
Vaccine; 2015 Jan; 33(5):604-9. PubMed ID: 25554240
[TBL] [Abstract][Full Text] [Related]
46. Extension study of participants from the trial of early aggressive therapy in juvenile idiopathic arthritis.
Wallace CA; Ringold S; Bohnsack J; Spalding SJ; Brunner HI; Milojevic D; Schanberg LE; Higgins GC; O'Neil KM; Gottlieb BS; Hsu J; Punaro MG; Kimura Y; Hendrickson A
J Rheumatol; 2014 Dec; 41(12):2459-65. PubMed ID: 25179849
[TBL] [Abstract][Full Text] [Related]
47. Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients.
Gerloni V; Pontikaki I; Gattinara M; Fantini F
Ann Rheum Dis; 2008 Aug; 67(8):1145-52. PubMed ID: 17981916
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept.
Borte S; Liebert UG; Borte M; Sack U
Rheumatology (Oxford); 2009 Feb; 48(2):144-8. PubMed ID: 19074187
[TBL] [Abstract][Full Text] [Related]
49. The TREAT study - trial or tribulation?
Lehman TJ
J Rheumatol; 2014 Jun; 41(6):1038-9. PubMed ID: 24882847
[No Abstract] [Full Text] [Related]
50. Anaphylaxis to etanercept in two children with juvenile idiopathic arthritis.
Crayne CB; Gerhold K; Cron RQ
J Clin Rheumatol; 2013 Apr; 19(3):129-31. PubMed ID: 23519173
[TBL] [Abstract][Full Text] [Related]
51. Anti-tumour necrosis factor therapy associated with cutaneous vasculitis.
Livermore PA; Murray KJ
Rheumatology (Oxford); 2002 Dec; 41(12):1450-2. PubMed ID: 12468829
[No Abstract] [Full Text] [Related]
52. [Remarkable improvement of the hip joint lesion in a patient with rheumatoid arthritis by the treatment with anti-TNF-α agents].
Nagare Y; Kinoshita K; Nishisaka F; Saito M; Nonaka T; Funauchi M
Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(5):272-6. PubMed ID: 21048388
[TBL] [Abstract][Full Text] [Related]
53. Bone status over 1 yr of etanercept treatment in juvenile idiopathic arthritis.
Simonini G; Giani T; Stagi S; de Martino M; Falcini F
Rheumatology (Oxford); 2005 Jun; 44(6):777-80. PubMed ID: 15741191
[TBL] [Abstract][Full Text] [Related]
54. Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
Otten MH; Anink J; Prince FH; Twilt M; Vastert SJ; ten Cate R; Hoppenreijs EP; Armbrust W; Gorter SL; van Pelt PA; Kamphuis SS; Dolman KM; Swart JF; van den Berg JM; Koopman-Keemink Y; van Rossum MA; Wulffraat NM; van Suijlekom-Smit LW
Ann Rheum Dis; 2015 Jul; 74(7):1379-86. PubMed ID: 24641940
[TBL] [Abstract][Full Text] [Related]
55. Etanercept in four children with therapy-resistant systemic juvenile idiopathic arthritis.
ten Cate R; van Suijlekom-Smit LW; Brinkman DM; Bekkering WP; Jansen-van Wijngaarden CJ; Vossen JM
Rheumatology (Oxford); 2002 Feb; 41(2):228-9. PubMed ID: 11886975
[No Abstract] [Full Text] [Related]
56. Thymic enlargement in a patient with juvenile idiopathic arthritis during etanercept therapy.
Sari I; Binicier O; Birlik M; Akar S; Yilmaz E; Kargi A; Onen F; Akkoc N
Rheumatol Int; 2009 Mar; 29(5):591-3. PubMed ID: 18810448
[TBL] [Abstract][Full Text] [Related]
57. 90K immunostimulatory glycoprotein in children with juvenile idiopathic arthritis.
Cecamore C; Marsili M; Salvatore R; Troiani R; D'Egidio M; Tinari N; Pelliccia P; Chiarelli F; Marcovecchio ML; Breda L
Mod Rheumatol; 2018 Jul; 28(4):637-641. PubMed ID: 29157059
[TBL] [Abstract][Full Text] [Related]
58. [Recommendations by the Pediatric and Adolescent Rheumatology Study Committee on therapy with Etanercept (p75 TNF-alpha receptor immunoglobulin fusion protein. Pharmacotherapy Committee].
Horneff G; Forster J; Seyberth HW; Michels H;
Z Rheumatol; 2000 Dec; 59(6):365-9. PubMed ID: 11201000
[No Abstract] [Full Text] [Related]
59. [Efficacy of etanercept in the treatment of juvenile idiopathic arthritis].
de Inocencio Arocena J; Merino Muñoz R; Alvarez Madrid C; García-Consuegra Molina J
An Pediatr (Barc); 2009 Apr; 70(4):354-61. PubMed ID: 19324597
[TBL] [Abstract][Full Text] [Related]
60. Effect of etanercept on refractory systemic-onset juvenile idiopathic arthritis.
Hu X; Yuan F; Zhang J; Yin L; Li BR; Jin YL
World J Pediatr; 2016 Feb; 12(1):96-102. PubMed ID: 25754755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
